|
Volumn 23, Issue 1, 2007, Pages 1-2
|
What does star*D tell us about ECT?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
CITALOPRAM;
LITHIUM;
MIRTAZAPINE;
NORTRIPTYLINE;
SERTRALINE;
VENLAFAXINE;
COGNITIVE THERAPY;
EDITORIAL;
ELECTROCONVULSIVE THERAPY;
HAMILTON SCALE;
HUMAN;
MAJOR DEPRESSION;
PSYCHOTHERAPY;
RANDOMIZATION;
REMISSION;
SYMPTOMATOLOGY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COMBINATION;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
OUTCOME ASSESSMENT;
RANDOMIZED CONTROLLED TRIAL;
ANTIDEPRESSIVE AGENTS;
COGNITIVE THERAPY;
COMBINED MODALITY THERAPY;
DEPRESSIVE DISORDER, MAJOR;
DRUG THERAPY, COMBINATION;
ELECTROCONVULSIVE THERAPY;
HUMANS;
MULTICENTER STUDIES;
OUTCOME ASSESSMENT (HEALTH CARE);
RANDOMIZED CONTROLLED TRIALS;
|
EID: 34247603547
PISSN: 10950680
EISSN: 15334112
Source Type: Journal
DOI: 10.1097/01.yct.0000263249.83549.34 Document Type: Editorial |
Times cited : (8)
|
References (4)
|